<DOC>
	<DOCNO>NCT01215357</DOCNO>
	<brief_summary>This study design test hypothesis ecopipam able reduce urge gamble patient diagnose Pathological Gambling .</brief_summary>
	<brief_title>Clinical Study Determine Ecopipam Can Reduce Urges Gamble</brief_title>
	<detailed_description>The purpose study determine ecopipam able stop urge gamble patient diagnose Pathological Gambling . Nerves communicate release chemical call `` neurotransmitter '' . One neurotransmitter brain call `` dopamine '' . After dopamine release nerve `` talk '' nerve interact receptor unique neurotransmitter . Ecopipam drug selectively block one family dopamine receptor . Some scientist believe urge gamble relate much dopamine brain . By block receptor dopamine us , ecopipam may able relieve urge gamble .</detailed_description>
	<mesh_term>Gambling</mesh_term>
	<mesh_term>Ecopipam</mesh_term>
	<criteria>Subject must diagnose Pathological Gambling accord DSMIV criterion Subject must least 2 episode gamble behavior within previous 2 week screen Subject must gamble urge least moderate intensity Subjects must unstable medical illness clinically significant abnormality lab test , ECG , physical exam Subjects major depressive episode within last 2 year Subjects history attempt suicide Subjects first degree relative major depressive episode result hospitalization , attempt complete suicide Subjects history epilepsy seizures Subjects myocardial infarction ( heart attack ) last 6 month Subjects lifetime history bipolar disorder , dementia , schizophrenia , psychotic disorder Subjects current recent DSMIV diagnosis substance abuse dependence ( exception nicotine )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Pathological Gambling</keyword>
	<keyword>ecopipam</keyword>
	<keyword>Dopamine</keyword>
</DOC>